Latest: FDA Approves New Biosimilar for Oncology Treatment

What Can We Learn From The FDA's List of Augmented and Virtual Reality Devices? - The Medical Futurist

0 Mins
While this list is not even comparable to that of AI-based medical devices, it sets a great example for other policy-makers and regulators to make their official lists public. The post What Can We Learn From The FDA’s List of Augmented and Virtual Reality Devices? appeared first on The Medical Futurist.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago